Key Takeaways
- Comcast (CMCSA) achieved a major milestone as its Peacock streaming platform turned profitable for the first time, reporting $189 million in adjusted EBITDA.
- RTX Corp (RTX) delivered a massive beat-and-raise quarter, boosting its FY26 revenue outlook to $95B–$96B driven by surging demand at Pratt & Whitney and Collins Aerospace.
- Tesla (TSLA) shares fell over 6% to session lows following the company's projection that capital expenditures will exceed $25 billion in 2026.
- Boeing (BA) received a boost as the FAA signaled that certification for the 737 Max 7 and Max 10 is expected in the "near term," potentially ending years of regulatory delays.
- Thermo Fisher (TMO) and Honeywell (HON) reported strong Q2 results, though Honeywell lowered its Free Cash Flow guidance significantly to $2 billion.
Media and Telecom: Peacock’s Turning Point
Comcast (CMCSA) reported a landmark second quarter for 2026, headlined by the Peacock streaming service reaching profitability. The platform generated $1.90 billion in revenue, surpassing the $1.76 billion estimate, and posted an adjusted EBITDA of $189 million, well above the $38 million analysts expected.
The company's overall revenue hit $29.94 billion, beating the $29.3 billion consensus. Growth was further supported by the domestic wireless segment, which added 448,000 lines, significantly outperforming the projected 384,333 additions.
Aerospace and Defense: RTX Leads, Boeing Gains Clarity
RTX Corp (RTX) posted dominant Q2 results, with adjusted EPS of $1.89 beating the $1.66 estimate. The company saw broad strength across its subsidiaries, with Pratt & Whitney sales reaching $8.89 billion and Collins Aerospace hitting $8.21 billion. Consequently, RTX raised its full-year adjusted sales guidance to a range of $95 billion to $96 billion.
In the broader aviation sector, Boeing (BA) shares reacted to news that the FAA is nearing certification for two critical aircraft variants. The 737 Max 7 is poised for approval by early August, while the 737 Max 10 is expected to win certification in the September/October window.
Industrial and Healthcare: Mixed Outlooks
Honeywell (HON) reported sales of $9.70 billion, slightly ahead of estimates, but missed on earnings with an adjusted EPS of $4.52 against the $4.81 expected. More notably, the company slashed its full-year Free Cash Flow guidance to $2 billion, a sharp drop from its previous range of $5.3 billion to $5.6 billion.
Thermo Fisher Scientific (TMO) outperformed expectations with adjusted EPS of $6.03 and revenue of $11.99 billion. The company’s organic revenue growth of 5% nearly doubled the analyst estimate of 2.98%, signaling a robust recovery in the life sciences sector.
Tech and Energy: Tesla Capex and LNG Disruptions
Tesla (TSLA) saw its stock price slide 6.1% during the session. Investor sentiment was dampened by the revelation that the EV maker expects capital expenditures to exceed $25 billion in 2026 as it continues to scale its AI infrastructure and new vehicle platforms.
In the energy markets, QatarEnergy has extended force majeure on LNG supplies to several Asian buyers. Trade sources indicate the company is leasing additional tankers through mid-October to navigate ongoing logistical challenges, potentially tightening global gas supplies.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.